BioElectronics Corporation Announces Key Management Addition

BioElectronics Corporation, (Pink Sheets: BIEL - News), is a developer and marketer of drug-free, anti-inflammatory patches. The Company announced today that Joseph M. Iglesias has joined the Company as Vice President of Design and Engineering.

Joe brings over fifteen years of product design, engineering and management experience in medical devices. He is a specialist in bioengineering and ergonomic design. Joe has designed and developed more than 20 innovative products in the fields of orthopedics, sports medicine, podiatry, chronic wound care and rehabilitation that have resulted in more than 25 patents in the US and worldwide. Joe received his BSME from University of California at Santa Barbara. Formerly, Joe was the Manager of Product Design for Royce Medical.

"We are very pleased to have attracted someone with Joe's wealth of medical device experience to lead our Design and Engineering Group. We are confident that Joe's skills, experience, and vision will greatly enhance our ability to rapidly introduce our pipeline of new products," said Todd Kislak, President of the Orthopedics Group.

ActiPatch(TM) Therapy is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few dollars a day. The patch delivery system and the Company's patented technology provides an inexpensive, self administered, equivalent of the operator administered pulsed electromagnetic energy therapy used extensively world-wide for decades to reduce swelling, relieve pain and enhance the healing of post-surgical incisions, chronic wounds and orthopedic conditions.

For more information visit http://www.bioelectronicscorp.com .

Safe Harbor Statement

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.




--------------------------------------------------------------------------------
Source: BioElectronics Corporation

Related Articles

• Leveraging the Future of Identity Management
  13 June 2005



• Kronos Furthers Leadership Position in Workforce Management
  13 June 2005



• Memory Experts International's ACCESS Management Suite Achieves Entrust Ready Status
  13 June 2005



• New Email Marketing Campaign Resources for Better Email Deliverability and Email Bounce Management
  12 June 2005



• Minority Alliance Capital Selects Tabitha Software to Provide Lease Management Technology Solution
  11 June 2005



• Ladenburg Thalmann Strengthens Management Team with Appointment of Senior Executives
  11 June 2005



• Indicative's IT Service Management Expands Its Global Reach on Four Continents
  10 June 2005



• Public Company Management Corporation Posts Liquigistics, Inc. SB-2 Contract with 10Q Filing
  31 May 2005



• EwingCole Names John Gerbner as President, COO; Realigns Top Management as Part of Ongoing Commitment
  31 May 2005



• Public Company Management Corporation Posts Liquigistics, Inc. SB-2 Contract with 10Q Filing
  31 May 2005